Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating and intertwined neurodegenerative diseases. Historically, ALS and FTD were considered distinct disorders given differences in presenting clinical symptoms, disease duration, and predicted risk of developing eac...

Descripción completa

Detalles Bibliográficos
Autores principales: Broce, Iris J., Castruita, Patricia A., Yokoyama, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956998/
https://www.ncbi.nlm.nih.gov/pubmed/33732107
http://dx.doi.org/10.3389/fnins.2021.639078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956998/
https://www.ncbi.nlm.nih.gov/pubmed/33732107
http://dx.doi.org/10.3389/fnins.2021.639078

Ejemplares similares